SMALL PEPTIDES

- The pursuit of new peptide drugs

WIESLAB BIOANALYTICAL SERVICES FOCUS AREA

SMALL PEPTIDES

Recent advancements in drug development technologies, combined with deepening understanding of biology, have fueled the pursuit of new peptide drugs.

Peptides exert a wide range of specific functions as chemical messengers, hormones, intracellular/intercellular mediators and as specific stimulators and inhibitors. Drugs can be produced either by purifying the peptide from a host, or by modifying and producing it as a more stable and clean form.

We have a deep understanding for the requirements of assay strategies for peptides, with a focus on immunogenicity, and can assist with immunogenicity risk assessment and assay strategies.

Let us help accelerate your small peptide drug development project!

Contact us to discuss your project with our scientists today! 

Contact Us

YOUR CHALLENGES 

Designing a fit for purpose bioanalytical program 

Common challenges when developing peptides;

  • Bioanalytical program design (i.e. assay design, what to validate, how to do samples analysis)
  • Reagent procurement and preparation

OUR EXPERINCE 

Our scientific team has vast experience in peptide drug development, bioanalytical ligand-based assay development/validation and sample analysis as wells as other bioanalytical assay strategies related to this area.  We have a special focus on immunogenicity related aspects within this field,

Whether you want to test your therapy in a cell biology assay, consisting of the elements of the tumor microenvironment, or in models using real patient tissue, we are here to help!

WHERE WE CAN HELP 


Setting proper risk assessment and help develop assay strategies

We offer service and expert knowledge within the following application areas: